🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Jennifer E. Amengual

Columbia University Irving Medical Center

ORCID: 0000-0003-4117-2469
MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Alliance A059102: A randomized phase II U.S. intergroup study of CHO(E)P versus CC-486-CHO(E)P versus duvelisib-CHO(E)P in previously untreated, CD30-negative, peripheral T-cell lymphomas.”.

Alliance A059102: A randomized phase II U.S. intergroup study of CHO(E)P versus CC-486-CHO(E)P versus duvelisib-CHO(E)P in previously untreated, CD30-negative, peripheral T-cell lymphomas.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.tps7593
N/A
0.241DataRank · unranked
4 citations

Susan M. Geyer, Stefan K. Barta, Jennifer E. Amengual, Travis Dockter, Chadwick Wright +8 more

Easy does it! New EZH2 inhibitor SHR2554 is safe and active in relapsed or refractory lymphoma

The Lancet Haematology(2022)10.1016/s2352-3026(22)00169-7
N/A
0DataRank · unranked
2 citations

Jennifer E. Amengual, Yun Kyoung Ryu

Context-defined cancer co-dependency mapping identifies a functional interplay between PRC2 and MLL-MEN1 complex in lymphoma

Nature Communications(2023)10.1038/s41467-023-39990-5
N/A
0DataRank · unranked
19 citations

Yinglu Li, Fang Zhu, Xinjing Xu, Brian Estrella, Manuel A. Pazos +12 more

S2207: RANDOMIZED PHASE II STUDY OF THE ADDITION OF TARGETED AGENTS TO TAFASITAMAB‐LENALIDOMIDE IN TRANSPLANT INELIGIBLE PATIENTS WITH RELAPSED/REFRACTORY LBCL

Hematological Oncology(2023)10.1002/hon.3166_ot22
N/A
0DataRank · unranked
1 citations

Patrick M. Reagan, H. Li, Hayder Saeed, Riha Vaidya, Joseph M. Unger +5 more

854 | SEQUENCING‐GUIDED CHEMOTHERAPY OPTIMIZATION USING REAL‐TIME EVALUATION IN NEWLY DIAGNOSED DLBCL WITH CIRCULATING TUMOR DNA: SHORTEN‐ctDNA

Hematological Oncology(2025)10.1002/hon.70096_854
N/A
0DataRank · unranked
0 citations

S. Meek, Costin Leu, Beatriz Raposo Corradini, Seda S. Tolu, Jennifer E. Amengual +3 more

Prognosis and Treatment of Plasmablastic Lymphoma in the United States: A Multicenter Retrospective Study

Research Square(2025)10.21203/rs.3.rs-7607922/v1
N/A
0DataRank · unranked
0 citations

Brian L. Egleston, Zachary AK Frosch, Ralphael Steiner, Ariela Noy, Veronica Carvajal +42 more